Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Slowing Down Stock
232.5700 5.88 (2.59%)
NSE Apr 30, 2025 15:31 PM
Volume: 32,762
 

232.57
2.59%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues remained flat YoY at | 285 crore (I-direct estimate: | 291 crore). Export formulations declined 20% YoY to | 74 crore (I-direct estimate: | 94 crore) while domestic formulations grew 12% to | 188 crore (I-direct estimate: | 177 crore) EBITDA margins declined 56 bps YoY to 14.4% (I-direct estimate of 14.2%) mainly on account of lower gross margins (64.8% in Q2FY18 vs. 65.5% in Q2FY17). EBITDA declined 2.4% YoY to | 41 crore (Idirect estimate: | 41 crore)...
Indoco Remedies Ltd. has an average target of 320.00 from 2 brokers.
More from Indoco Remedies Ltd.
Recommended